

Interpreting DAT Imaging Results in the Clinical Context
Aug 15, 2024
Dr. Jeff Ratliff, a specialist in DAT imaging, joins Dr. Eduardo De Pablo-Fernández, an expert on Parkinsonian disorders, to discuss the critical role of dopamine transporter imaging in diagnosis. They explore how DAT imaging can effectively differentiate between Parkinson's disease and multiple system atrophy, while also addressing its limitations in tau-related conditions. Key insights include the influence of alpha-synuclein on neurodegenerative disorders and the challenges of interpreting imaging results, particularly for progressive supranuclear palsy.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 4min
Analyzing Alpha-Synuclein Mediated Disorders Through Patient Imaging Data
03:32 • 3min
Interpreting DAT Imaging in Parkinsonism
06:16 • 8min
Assessing the Utility of DAT Imaging in Progressive Supranuclear Palsy
13:47 • 2min
Navigating DAT Imaging Challenges in Progressive Supranuclear Palsy Diagnosis
15:29 • 3min